{"id":"W2998576867","doi":"10.1111/bjd.18662","title":"How many people develop anti-drug antibodies to the biologic drug tildrakizumab, and what impact does this have on the effectiveness of their treatment","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Drug; Clinical trial; Adverse effect; Antibody; Pharmacokinetics; Incidence (geometry); Internal medicine; Psoriasis; Pharmacology; Immunology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006191853,0.0002307151,0.000826333,0.00006515547,0.0002327721,0.0001294306,0.0003629103,0.0001658014,0.00007561622],"category_scores_gemma":[0.0004797501,0.00009865976,0.0002298983,0.0001706045,0.0004251926,0.0001445317,0.0001247309,0.0003707199,0.000006257329],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002979983,"about_ca_system_score_gemma":0.00007006548,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007125671,"about_ca_topic_score_gemma":0.0001022497,"domain_scores_codex":[0.9968916,0.002136417,0.0003804502,0.0002269567,0.00004883267,0.0003157617],"domain_scores_gemma":[0.99722,0.002095628,0.0002874028,0.0001536063,0.0001834752,0.0000598467],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.008433749,0.001702764,0.2870535,0.0006082179,0.01051691,0.002384074,0.01736675,0.00002103393,0.2258345,0.003095375,0.04576369,0.3972194],"study_design_scores_gemma":[0.003093311,0.001439094,0.2955636,0.0008155758,0.0003645845,0.02632857,0.009413654,0.00002030272,0.6415461,0.0009688678,0.01996597,0.0004803129],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9384313,0.01818233,0.0001222135,0.04250773,0.0003398878,0.000307451,0.00005996482,0.000009400196,0.00003972127],"genre_scores_gemma":[0.9904177,0.008279265,0.0001191595,0.001073271,0.00003651965,0.000005919182,0.000004313702,0.00001115577,0.00005274001],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4157116,"threshold_uncertainty_score":0.4023228,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01657219271445521,"score_gpt":0.2646796761144864,"score_spread":0.2481074834000312,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}